Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 177 Lung Neoplasms 56 Neoplasms 14 NSCLC 11 Brain Neoplasms 11 Neoplasm Metastasis 10 Carcinoma 9 Meningeal Carcinomatosis 6 Colorectal Neoplasms 5 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms by Site 3 Lung Diseases 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2 Neoplasms, Nerve Tissue 2

Interventions

icotinib 2 osimertinib 1 aflutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

EGF-R Positive Non-Small Cell Lung Cancer × osimertinib × Clear all

NCT04965701 2023-11-13

FLOWER

Istituto Oncologico Veneto IRCCS

EGF-R Positive Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡